Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Non disclosure agreement

1,214 views

Published on

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

Non disclosure agreement

  1. 1. Inventory0 Confidential Information0 Non-Confidential Agreement0 Life of NDA0 Types of NDA0 Case Studies0 Analysis0 Conclusion0 References
  2. 2. Confidential Information 0 Not Much Popular as Compare to other IP. 0 Seeking attention Slowly. 0 Trade Secret or Business Secret. 0 TRIPS Article 39(2) Protects Confidential information. 0 Economic Value & Secret: - Necessities. 0 Transfer with the employee. 0 Governed by Common Law & Law of Contract, 1872. 0
  3. 3. Non-Confidential Agreement0 Legally binding agreement.0 Between a discloser of confidential information, and a recipient of confidential information.0 Deals with the terms upon which the confidential information is disclosed.0 Other names, such as Confidentiality Deeds, Mutual Disclosure Agreement, Secrecy Agreement.
  4. 4. Life Of NDA 0 Obligations of confidentiality come to an end in each of the following events: 0 The confidential information enters the public domain. 0 The recipient receives the confidential information from another. 0 person entitled to disclose it, without any obligation of confidentiality. 0 The recipient can demonstrate it was independently developed by the recipient. 0 Biotechnology Sector:- 5 to 7 years
  5. 5. Types of NDA One Way NDA Two Way NDA
  6. 6. Case Studies 0 Force India v Aero Lab SRL. 0 Infosys Case. 0 Emergent Genetics v. Shailendra Shivam.
  7. 7. Analysis 0 Emphasis on clauses of the agreement. 0 Role of exit interviews. 0 Steps other than NDA.
  8. 8. Conclusion “Precaution is better than cure”
  9. 9. References 0 http://www.wipo.int/sme/en/documents/disclosing_ inf.htm 0 http://www.tms.org/pubs/journals/JOM/matters/m atters-9405.html 0 http://www.wipo.int/sme/en/documents/pharma_li censing.html#P222_12189

×